We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002352:SZSES.F. Holding Co., Ltd. Analysis

Data as of 2026-08-31 - not real-time

CN¥31.80

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

S.F. Holding Co., Ltd. is priced at ¥31.80, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 6.4%. Momentum indicators put RSI at 36.8 (approaching oversold) with MACD reading bearish. The recent range runs from support at ¥31.60 up to resistance at ¥35.15.
On valuation the read is undervalued — earnings multiple of 14.0 versus a 29.4 sector average, below the peer group. Consensus targets land 46.0% above where the shares trade now. Revenue is growing at 5.7% on a 3.4% profit margin. The 2.64% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 23.3%, a beta of -0.01 and a maximum drawdown of 28.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top Market Events

SF Holding Co Ltd goes ex-dividend today, May 12, 2026, with a payment of 0.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 36.32
  • MACD momentum is negative
  • 30-day price change of -6.4%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 14.0 versus sector average of 29.4
  • Trading below the 200-day average of 36.32
  • Analyst targets imply +46.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 14.0 versus sector average of 29.4
  • Analyst targets imply +46.0% versus the current price
  • Dividend yield of 2.64%

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin3.43%
P/E Ratio14.0
ROE10.56%
ROA4.07%
Debt/Equity51.13
P/B Ratio1.6
Op. Cash FlowCN¥25.8B
Free Cash FlowCN¥6.5B
Industry P/E29.4

Technical Analysis

TrendNeutral
RSI36.8
SupportCN¥31.60
ResistanceCN¥35.15
MA 20CN¥33.17
MA 50CN¥33.04
MA 200CN¥36.32
MACDBearish
VolumeIncreasing
Fear & Greed Index94.18

Valuation

Fair ValueCN¥17.95
Target PriceCN¥46.42
Upside/Downside45.96%
GradeUndervalued
TypeBlend
Dividend Yield2.64%

Risk Assessment

Beta-0.01
Volatility23.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.